» Articles » PMID: 26154574

Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2015 Jul 9
PMID 26154574
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Small nodal tumor infiltrates (SNTI)-defined as isolated tumor cells and micrometastases-are associated with worse disease-free and overall survival in stage I and II colon cancer patients. Their detection, however, remains challenging. The objective of the present study was to evaluate whether there is a correlation between the location of SNTI and phagocytosed carbon dye particles in sentinel lymph nodes (SLN) of colon cancer patients.

Materials And Methods: Isosulfan blue and carbon dye were injected intraoperatively near the tumor to mark the SLN. Serial sections of SLN were stained with hematoxylin-eosin and immunohistochemistry. Intranodal distribution of phagocytosed carbon particles was compared to the presence of SNTI.

Results: Of a cohort of 159 patients, 24 patients had SNTI in their lymph nodes (LN). SNTI were found in a total of 116 LN of which 66 were SLN and 50 were non-SLN. In 59, these 116 LN with SNTI phagocytosed carbon dye were found (50.9 %). Phagocytosed carbon dye was identified significantly more often in SLN (49 of 66 SNTI positive SLN) compared to 10 of 50 SNTI positive non-SLN (p < 0.001). In 52 out of 59 LN (88.1 %), phagocytosed carbon dye was in close proximity to SNTI.

Conclusions: In the majority of patients, SNTI are located in the same SLN compartment as phagocytosed carbon dye particles. Our investigation provides evidence that the use of carbon dye facilitates SNTI detection and improves LN staging in colon cancer. Therefore, the concept of intranodal mapping-which has been previously described for melanoma-can be extended to colon cancer patients.

Citing Articles

Sentinel lymph node biopsy with carbon dye in endometrial cancer: a single center, prospective cohort study.

Minareci Y, Sozen H, Altinkara Hacioglu B, Yuvanc H, Topuz S, Salihoglu M Surg Endosc. 2024; 38(3):1608-1616.

PMID: 38291161 PMC: 10881722. DOI: 10.1007/s00464-023-10662-1.


The Value of Sentinel Lymph Node Mapping for the Staging of Node-Negative Colon Cancer: Propensity Score and Mediation Analyses.

Weixler B, Ramser M, Warschkow R, Viehl C, Vaughan-Shaw P, Zettl A Ann Surg Open. 2023; 2(3):e084.

PMID: 37635823 PMC: 10455289. DOI: 10.1097/AS9.0000000000000084.


Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies.

Lucas K, Melling N, Giannou A, Reeh M, Mann O, Hackert T Cancers (Basel). 2023; 15(12).

PMID: 37370806 PMC: 10296374. DOI: 10.3390/cancers15123196.


Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study.

Weixler B, Viehl C, Warschkow R, Guller U, Ramser M, Sauter G JAMA Surg. 2017; 152(10):912-920.

PMID: 28593306 PMC: 5710278. DOI: 10.1001/jamasurg.2017.1514.


Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial.

Weixler B, Rickenbacher A, Raptis D, Viehl C, Guller U, Rueff J World J Surg. 2017; 41(9):2378-2386.

PMID: 28508233 DOI: 10.1007/s00268-017-4051-2.

References
1.
Koyanagi K, Bilchik A, Saha S, Turner R, Wiese D, McCarter M . Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res. 2008; 14(22):7391-6. PMC: 2586882. DOI: 10.1158/1078-0432.CCR-08-0290. View

2.
Viehl C, Guller U, Hamel C, Riehle H, Plaass C, Marti W . Carbon dye staining of sentinel lymph nodes facilitates microstaging of colon cancer patients. World J Surg. 2006; 30(3):453-6. DOI: 10.1007/s00268-005-0336-y. View

3.
Leong S, Zuber M, Ferris R, Kitagawa Y, Cabanas R, Levenback C . Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. J Surg Oncol. 2011; 103(6):518-30. DOI: 10.1002/jso.21815. View

4.
Stojadinovic A, Nissan A, Protic M, Adair C, Prus D, Usaj S . Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg. 2007; 245(6):846-57. PMC: 1876962. DOI: 10.1097/01.sla.0000256390.13550.26. View

5.
Bilchik A, Saha S, Wiese D, Stonecypher J, Wood T, Sostrin S . Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol. 2001; 19(4):1128-36. DOI: 10.1200/JCO.2001.19.4.1128. View